US Pharma MarketingPfizer furthers pneumococcal efforts, remains ‘comfortable’ taking on emerging threats: vaccine chief
After decades of developing vaccines to shield babies and adults from Streptococcus pneumonia infections, Pfizer is now taking another leap forward in its efforts to protect against one of the bact After decades of developing vaccines to shield babies and adults from Streptococcus pneumonia infections, Pfizer is now taking another leap forward in its efforts to protect against one of the bacteria’s most dangerous strains—all while keeping an eye on the world’s several emerging global health threats. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending…
After decades of developing vaccines to shield babies and adults from Streptococcus pneumonia infections, Pfizer is now taking another leap forward in its efforts to protect against one of the bacteria’s most dangerous strains—all while keeping an eye on the world’s several emerging global health threats.
Source: FierceBiotech